A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

1,805

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

erlotinib [Tarceva]

150 mg/day until progressive disease or unacceptable toxicity

Trial Locations (94)

3010

Alicante

10003

Cáceres

11009

Cadiz

11207

Algeciras

11407

Jerez de la Frontera

11510

Puerto Real

12002

Castellon

14004

Córdoba

15006

A Coruña

15009

A Coruña

15405

Ferrol

17007

Girona

18003

Granada

18014

Granada

18800

Baza

20014

Donostia / San Sebastian

21005

Huelva

23007

Jaén

24071

León

25198

Lleida

27004

Lugo

28002

Madrid

28006

Madrid

28033

Madrid

28034

Madrid

28040

Madrid

28041

Madrid

28046

Madrid

28222

Madrid

28660

Madrid

28922

Alcorcón

28935

Madrid

29010

Málaga

30008

Murcia

30120

Murcia

30203

Cartagena

31008

Navarra

Pamplona

32005

Ourense

34005

Palencia

35016

Las Palmas de Gran Canaria

35020

Las Palmas de Gran Canaria

36204

Vigo

36211

Vigo

37007

Salamanca

38010

Santa Cruz de Tenerife

38320

San Cristóbal de La Laguna

39008

Santander

40002

Segovia

41009

Seville

41013

Seville

41014

Seville

Valencia

46009

Valencia

46010

Valencia

46015

Valencia

46017

Valencia

46026

Valencia

46520

Sagunto

47010

Valladolid

48013

Bilbao

48903

Barakaldo

50009

Zaragoza

03804

Alcoy

03203

Elche

04009

Almería

05071

Ávila

06080

Badajoz

06400

Don Benito

06800

Mérida

07800

Ibiza Town

07012

Palma de Mallorca

07014

Palma de Mallorca

07198

Palma de Mallorca

08911

Badalona

08003

Barcelona

08017

Barcelona

08022

Barcelona

08029

Barcelona

08036

Barcelona

08041

Barcelona

08227

Barcelona

08907

Barcelona

08916

Barcelona

08400

Granollers

08243

Manresa

08304

Mataró

08208

Sabadell, Barcelona

08923

Sant Coloma Gramenet

08810

Sant Pere de Ribes

08221

Terrassa

08500

Vic

09006

Burgos

03180

Torrevieja

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01996332 - A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter